UA105352C2 - Method for preventing fetoplacental dysfunction in pregnant patients with iron deficiency anemia in setting of chronic urogenital infection - Google Patents
Method for preventing fetoplacental dysfunction in pregnant patients with iron deficiency anemia in setting of chronic urogenital infectionInfo
- Publication number
- UA105352C2 UA105352C2 UAA201304674A UAA201304674A UA105352C2 UA 105352 C2 UA105352 C2 UA 105352C2 UA A201304674 A UAA201304674 A UA A201304674A UA A201304674 A UAA201304674 A UA A201304674A UA 105352 C2 UA105352 C2 UA 105352C2
- Authority
- UA
- Ukraine
- Prior art keywords
- day
- days
- fetoplacental
- dysfunction
- preventing
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to medicine, namely to a method for preventing fetoplacental dysfunction in the pregnant patients with iron deficiency anemia in the setting of the chronic urogenital infection. The method comprises antianemic, detoxifying therapy including Sorbifer-durules as iron-containing composition, 1 tablet twice a day for 30-40 days, Actovegin, 1 pellet thrice a day fro 12-14 days accompanied with intravenous dropwise administration of the ozonized solution at ozone concentration of 2.4-2.6 mg/L every other day for 7-8 days in combination with Genferon suppositories 250000 IU vaglnally twice a day for 10-12 days at the gestation term of 26-28 weeks and the repeated course in 3-4 weeks if necessary.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAA201304674A UA105352C2 (en) | 2013-04-15 | 2013-04-15 | Method for preventing fetoplacental dysfunction in pregnant patients with iron deficiency anemia in setting of chronic urogenital infection |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAA201304674A UA105352C2 (en) | 2013-04-15 | 2013-04-15 | Method for preventing fetoplacental dysfunction in pregnant patients with iron deficiency anemia in setting of chronic urogenital infection |
Publications (1)
Publication Number | Publication Date |
---|---|
UA105352C2 true UA105352C2 (en) | 2014-04-25 |
Family
ID=52281795
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201304674A UA105352C2 (en) | 2013-04-15 | 2013-04-15 | Method for preventing fetoplacental dysfunction in pregnant patients with iron deficiency anemia in setting of chronic urogenital infection |
Country Status (1)
Country | Link |
---|---|
UA (1) | UA105352C2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2649127C1 (en) * | 2017-04-20 | 2018-03-29 | Федеральное бюджетное учреждение науки "Московский научно-исследовательский институт эпидемиологии и микробиологии им. Г.Н. Габричевского" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека | Method of management of pregnancy with infectious pathology of urogenital tract |
-
2013
- 2013-04-15 UA UAA201304674A patent/UA105352C2/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2649127C1 (en) * | 2017-04-20 | 2018-03-29 | Федеральное бюджетное учреждение науки "Московский научно-исследовательский институт эпидемиологии и микробиологии им. Г.Н. Габричевского" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека | Method of management of pregnancy with infectious pathology of urogenital tract |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2016006177A (en) | Method of engineering chemotherapy drug resistant t-cells for immunotherapy. | |
NZ700881A (en) | Compositions and methods comprising celecoxib or related compounds and dextromethorphan | |
NZ713868A (en) | Treatment of cancer using coenzyme q10 combination therapies | |
MX2022008236A (en) | Methods of administering high concentrations of nitric oxide. | |
MX2017005134A (en) | Treatment of cancer with immune stimulators. | |
NZ717504A (en) | Methods of treatment of cancer by continuous infusion of coenzyme q10 | |
MX2017006938A (en) | Combination therapy for treatment of cancer. | |
MX2016011333A (en) | Drug delivery systems and methods for treatment of bladder cancer with gemcitabine. | |
NZ720273A (en) | Preparations and methods for treating a gd2 positive cancer | |
UA105352C2 (en) | Method for preventing fetoplacental dysfunction in pregnant patients with iron deficiency anemia in setting of chronic urogenital infection | |
NZ712584A (en) | Antitumor agent including irinotecan hydrochloride hydrate | |
UA79767U (en) | Method for treating cerebral ischemic stroke with abnormalities of intracerebral and precerebral arteries in acute period | |
RU2012115039A (en) | METHOD FOR TREATING CHRONIC ENDOMETRITIS | |
UA89638U (en) | Method for treating aged patients with syndrome of vascular cognitive impairment | |
RU2012156689A (en) | METHOD FOR TREATING AN ENDOGENOUS INTOXICATION SYNDROME DUE TO HYPERPROTEOLYSIS | |
UA90868U (en) | Method for preventing contrast-induced nephropathy | |
MD520Y (en) | Method for postoperative treatment of patients with nephrolithiasis | |
UA71534U (en) | Method for treating acute ischemic stroke | |
UA82717U (en) | Method for treatment of acute ischemic stroke, burdened with ischemic heart disease | |
UA100291U (en) | Method for detoxification | |
NZ776617A (en) | Methods of conditioning patients for t cell therapy | |
UA94010U (en) | Method for treating adenomyosis in women | |
UA81697U (en) | Method for treating iron-deficiency anemia in pregnant patients with pulmonary tuberculosis | |
UA104128U (en) | Method for treatment of acute ischemic stroke | |
UA81924U (en) | Method for treating patients with hiv/aids-associated chemoresistant tuberculosis |